Jennifer Foltz, PhD

Research Program Hematopoietic Development & Malignancy
Jennifer Foltz

Researcher Background

Primary Academic Title

Assistant Professor, Department of Internal Medicine, WashU Medicine

Training

  • 2017 - 2018: Postdoctoral Fellow, The Research Institute at Nationwide Children's Hospital, Columbus, OH
  • 2018 - 2022: Postdoctoral Scholar, WashU Medicine, St. Louis, MO

Education

  • 2010: BS in Psychology, Indiana University Purdue University, Indianapolis, IN
  • 2012: MS in Cellular & Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN
  • 2017: PhD in Immunology, University of Texas MD Anderson Cancer Center, Houston, TX

Research & Selected Publications

Research Interest

My research interests lie in integrating and applying novel computational biology techniques with mechanistic experimental immunology to understand drivers of response and resistance to NK cell therapies for cancer.

Research Publications

A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.
Authors:

Pilcher WC, Yao L, Gonzalez-Kozlova E, one or more additional authors omitted Foltz JA, one or more additional authors omitted Bhasin M

Journal & Year:

Nat Cancer • 2026

Large B cell lymphoma microenvironment archetype profiles.
Authors:

Li X, Singhal K, Deng Q, one or more additional authors omitted Foltz JA, one or more additional authors omitted Green MR

Journal & Year:

Cancer Cell • 2025

Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation.
Authors:

Foltz JA, Tran J, Wong P, one or more additional authors omitted Fehniger TA

Journal & Year:

Sci Immunol • 2024

Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation.
Authors:

Cubitt CC, Wong P, Dorando HK, Foltz JA, one or more additional authors omitted Fehniger TA

Journal & Year:

J Clin Invest • 2024

Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer.
Authors:

Jacobs MT, Wong P, Zhou AY, one or more additional authors omitted Foltz JA, one or more additional authors omitted Fehniger TA

Journal & Year:

Clin Cancer Res • 2023